First Patient Treated in Multi-Center Pivotal Study of Eye90 microspheres in Hepatocellular Carcinoma
HALIFAX, NS, Oct. 25, 2023. ABK Biomedical, Inc., an innovative, medical device company dedicated to the research, development, and commercialization of advanced imageable embolic medical devices, today announced the first patient treated in its...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Clinical Trials | Hepatocellular Carcinoma | Liver Cancer | Medical Devices | Pharmaceuticals | Study